Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics · 2024-08 · 119 (5) · 1493-1505
DOI: 10.1016/j.ijrobp.2024.02.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-08. Verfasst von Ron J Leavitt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Laboratory, Department of Radiation Oncology, Lausanne, University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Pyrimidinones, Tumor Hypoxia, Glioblastoma, Glycolysis. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, Swiss National Science Foundation.
Abstract (Originalsprache)
PURPOSE: Tumor hypoxia is a major cause of treatment resistance, especially to radiation therapy at conventional dose rate (CONV), and we wanted to assess whether hypoxia does alter tumor sensitivity to FLASH. METHODS AND MATERIALS: We engrafted several tumor types (glioblastoma [GBM], head and neck cancer, and lung adenocarcinoma) subcutaneously in mice to provide a reliable and rigorous way to modulate oxygen supply via vascular clamping or carbogen breathing. We irradiated tumors using a single 20-Gy fraction at either CONV or FLASH, measured oxygen tension, monitored tumor growth, and sampled tumors for bulk RNAseq and pimonidazole analysis. Next, we inhibited glycolysis with trametinib in GBM tumors to enhance FLASH efficacy. RESULTS: Using various subcutaneous tumor models, and in contrast to CONV, FLASH retained antitumor efficacy under acute hypoxia. These findings show that in addition to normal tissue sparing, FLASH could overcome hypoxia-mediated tumor resistance. Follow-up molecular analysis using RNAseq profiling uncovered a FLASH-specific profile in human GBM that involved cell-cycle arrest, decreased ribosomal biogenesis, and a switch from oxidative phosphorylation to glycolysis. Glycolysis inhibition by trametinib enhanced FLASH efficacy in both normal and clamped conditions. CONCLUSIONS: These data provide new and specific insights showing the efficacy of FLASH in a radiation-resistant context, proving an additional benefit of FLASH over CONV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Radiation Oncology Laboratory, Department of Radiation Oncology, Lausanne, University Hospital and University of Lausanne, Lausanne, Switzerland.
- Institute of Radiation Physics, University Hospital and University of Lausanne, Lausanne, Switzerland.
- Radiation Oncology Laboratory, Department of Radiation Oncology, Lausanne, University Hospital and University of Lausanne, Lausanne, Switzerland; Radiation Oncology Department, Iridium Netwerk, Wilrijk (Antwerp), Belgiu…
- Department of Radiation Oncology, University of California, Irvine, California.
- Radiation Oncology Laboratory, Department of Radiation Oncology, Lausanne, University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: marie-catherine.vozenin@hcuge.ch.
Förderung
- NCI NIH HHS
- National Institutes of Health
- Swiss National Science Foundation
Zitieren
APA
Leavitt, R. J., Almeida, A., Grilj, V., Montay-Gruel, P., Godfroid, C., Petit, B., Bailat, C., Limoli, C. L., & Vozenin, M. C. (2024). Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics, 119(5), 1493-1505. https://doi.org/10.1016/j.ijrobp.2024.02.015
Vancouver
Leavitt RJ, Almeida A, Grilj V, Montay-Gruel P, Godfroid C, Petit B, et al. Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2024;119(5):1493-1505. doi:10.1016/j.ijrobp.2024.02.015
BibTeX
@article{Leavitt2024,
author = {Leavitt, Ron J and Almeida, Aymeric and Grilj, Veljko and Montay-Gruel, Pierre and Godfroid, Céline and Petit, Benoit and Bailat, Claude and Limoli, Charles L and Vozenin, Marie-Catherine},
title = {Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
volume = {119},
number = {5},
pages = {1493--1505},
doi = {10.1016/j.ijrobp.2024.02.015}
}
EUVIMED